To determine the possible effects of IGF2BP3 knockdown on cancer cell apoptosis, we treated the OCCC cells with NC, siIGF2BP3-1, or siIGF2BP3-2 and detected apoptotic cells after siIGF2BP3 treatment in both ES2 (siIGF2BP3-1: 22.3%; siIGF2BP3-2: 15.23%) and OVMANA (siIGF2BP3-1: 8.65%; siIGF2BP3-2: 7.6%) cell lines (Figure 8). Here, IGF2BP3 is linked to cancer.